Production & Manufacturing

Leanings In The Biopharma Contract Manufacturing For 2022

A recent survey found that 86.9% of biopharmaceutical businesses outsource at least a portion of their operations, which has contributed to the $14 billion market...

FTC Aims Manufacturer, PBM Rebates For Rising Insulin Costs

Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US regulators, with a particular focus on rising insulin prices. The...

Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production

COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take, for example, Pfizer's new $120 million investment. The company announced...

RCPE and InSilicoTrials to Digitalize and Accelerate the Development...

RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialize the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows companies to assess...

PIPAc Collaboration Enables New Compact, Mobile and Frugal Approach...

The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API)...

Catalent Invests $175 Million In A New Factory Expansion

Catalent, a manufacturing behemoth, has announced another expansion, this time at a large oral medication plant that had previously doubled in size in 2015. Catalent is...

PCI Pharma Services Announces Major Manufacturing Expansion with $100...

PCI Pharma Services is pleased to announce a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important manufacturing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read